Full Breakdown
Trump Administration Revamps Biosecurity Policy Amid AI-Driven Threats
8/18/2026, 1:50:23 AM
Core Event: Staffing cuts and new AI-focused biosecurity efforts
The White House has been reshaping its approach to biological security after the Trump administration eliminated the dedicated biosecurity team that existed at the end of the Biden term. The administration also rescinded a 2023 executive order that called for stronger safeguards on artificial-intelligence (AI) systems capable of creating synthetic pathogens, and it has questioned a 2024 policy that required companies selling genetic components to screen customers. While President Donald Trump has called for a revised executive order by August 2025, no new order has yet been issued.
Background & Context: Prior structure and policy foundations
By the close of President Joe Biden’s tenure, roughly 30 experts comprised a White House team focused on biological security, according to the Washington Post. When Trump returned to office, that team was disbanded, leaving periods with no White House official solely responsible for biosecurity. The administration also shuttered the Office of Pandemic Preparedness and Response Policy and a National Security Council unit dedicated to health security, and fragmented parts of the Office of the Director of National Intelligence and the Department of Homeland Security that dealt with biological threats. The Office of Pandemic Preparedness and Response Policy was later reopened in the spring following an Ebola outbreak in the Democratic Republic of the Congo, though experts consider the reopening insufficient.
Official Statements & Responses
A White House official told the Washington Post that the administration is working to strengthen the limited Biden-era biosecurity framework, emphasizing that staffing changes have not been fully addressed. The official noted that policy development has been ongoing for more than a year, including work on the administration’s AI Action Plan released last summer. An OpenAI spokeswoman said the company has continued its partnership with the administration, highlighting a special version of GPT—named “Rosalind”—designed for biodefense applications.
Data & Statistics
- Approximately 30 biosecurity experts were on the White House team at the end of the Biden administration.
- The 2023 executive order on AI-related biological safeguards was revoked.
- A 2024 policy requiring customer screening for genetic component sales remains under debate.
- President Trump has set an August 2025 deadline for a revised executive order.
- The Office of Pandemic Preparedness and Response Policy was reopened in the spring after the Congo Ebola outbreak.
- OpenAI hosted more than 50 government experts at a summit in July 2025 to discuss AI’s role in biodefense.
What’s Next: Ongoing initiatives and timeline
The administration’s AI Action Plan, drafted last summer, continues to guide policy development. A new initiative announced earlier this month involves the White House cybersecurity office and a senior official from the Department of Health and Human Services. Multiple briefings between the White House, OpenAI, and other agencies on biological risks have been reported, and the administration is expected to issue a revised executive order by the August 2025 deadline.
